Davide Ramoni

41 posts

Davide Ramoni banner
Davide Ramoni

Davide Ramoni

@DavideRamoni

MD, Internal Medicine specialist PhD student (TaCIM) in joint supervision @UniGenova @USI_university Science and football enthusiast

Katılım Şubat 2024
81 Takip Edilen12 Takipçiler
Sabitlenmiş Tweet
Davide Ramoni
Davide Ramoni@DavideRamoni·
🫀 Despite modern therapies, residual cardiovascular risk remains high. JCAD emerges as a promising target to address residual CV risk in patients with acute coronary syndrome. 📖 Read our publication in European Heart Journal 🚀 @ehj_ed @escardio academic.oup.com/eurheartj/arti…
Davide Ramoni tweet mediaDavide Ramoni tweet media
English
1
2
2
206
Davide Ramoni retweetledi
Simon Kraler
Simon Kraler@KralerSimon·
Check out our study with @liberale_luca on a novel therapeutic target for coronary artery disease: #JCAD @CarboneF82 @DavideRamoni @HemostasisToday @escardio @TomLuscher @EHJACVCEiC @cescobruno @UZH_en
EHJ Editor-in-Chief@ehj_ed

Residual risk in acute coronary syndromes is increasigly debated. The junctional protein associated with coronary artery disease might play a relevant role according to a new study. doi.org/10.1093/eurhea… #ACS #cardiotwitter, @ESC_Journals, @escardio

English
0
2
3
134
Davide Ramoni
Davide Ramoni@DavideRamoni·
🫀 A major avenue for cardiovascular research ahead. JCAD emerges as a promising target to tackle residual cardiovascular risk in ACS patients. 📖 Read our publication in European Heart Journal 🔗 academic.oup.com/eurheartj/adva… #HeartHealth #Research #Cardiology
EHJ Editor-in-Chief@ehj_ed

Residual risk in acute coronary syndromes is increasigly debated. The junctional protein associated with coronary artery disease might play a relevant role according to a new study. doi.org/10.1093/eurhea… #ACS #cardiotwitter, @ESC_Journals, @escardio

English
0
0
0
39
Davide Ramoni
Davide Ramoni@DavideRamoni·
🫀 Despite modern therapies, residual cardiovascular risk remains high. JCAD emerges as a promising target to address residual CV risk in patients with acute coronary syndrome. 📖 Read our publication in European Heart Journal 🚀 @ehj_ed @escardio academic.oup.com/eurheartj/arti…
Davide Ramoni tweet mediaDavide Ramoni tweet media
English
1
2
2
206
Davide Ramoni
Davide Ramoni@DavideRamoni·
Joint symposium with the @escardio Council at the #SIC86 congress in Rome — promoting science, dialogue, and innovation to improve cardiovascular health in Europe.
Davide Ramoni tweet media
English
0
0
0
33
Davide Ramoni retweetledi
European Journal of Clinical Investigation
European Journal of Clinical Investigation@EJCI_News·
🔥An absolute must read! EDITORIAL Wiley Online Library Atrial fibrosis heterogeneity and atrial fibrillation risk in ischaemic heart failure ➡️ doi.org/10.1111/eci.70… ✍️AlessandroScuricini FabrizioMontecucco LucaLiberale AldoBonaventura FedericoCarbone Davide Ramoni @UniGenova @SanMartino_Ge @liberale_luca @CarboneF82 @aldobonaventura @DavideRamoni #atrialfibrillation #atrialfibrosis #inflammation #ischaemicheartfailure
European Journal of Clinical Investigation tweet media
Română
0
2
3
123
Socios.com
Socios.com@socios·
🔥GIVEAWAY TIME🔥 250,000 Reward Points up for grabs, and it couldn't be easier to enter: ➡️ Follow @FanTokens ❤️ Like This Post Winners will be announced in 10 days! Good luck.
Socios.com tweet media
English
357
434
2K
70.1K
Davide Ramoni retweetledi
Luca Liberale
Luca Liberale@liberale_luca·
🚨 Exciting News! 🚨 Join us in Genoa, May 2025 for the @ESCI_Society Annual Meeting, co-organized by @carboneF82 & me! 🌍🔬 📢 Early bird registration is now OPEN & abstract submission is live! 🔗 More info & registration: esci.eu.com 🧵👇 Why you should attend?
Luca Liberale tweet media
English
1
11
22
1.9K
Davide Ramoni retweetledi
Henry Han
Henry Han@HanCardiomd·
Coffee drinking timing and mortality in US adults ☕️40,725 adults (NHANES 1999–2018) & 1,463 adults (Lifestyle Validation Study). ☕️Morning coffee drinkers (36%) had lower risks of all-cause ☠️ (HR: 0.84) & CVD ☠️ (HR: 0.69) vs. non-coffee drinkers. ☕️All-day coffee drinkers (14%) showed no significant benefit academic.oup.com/eurheartj/adva… @ESC_Journals @ehj_ed ☕️🤎☕️
Henry Han tweet mediaHenry Han tweet mediaHenry Han tweet media
English
7
21
64
11.8K
Davide Ramoni retweetledi
Simon Kraler
Simon Kraler@KralerSimon·
Check out our #ESCCongress 2024 simultaneous #CardioOncology publication on a novel risk score for MACE in cancer patients - now online @JTHjournal jthjournal.org/article/S1538-… Lucky me to have such a great team! Many thanks to @liberale_luca @Cihan_Ay_MD @FlorianMoik @TomLuscher
Simon Kraler tweet media
JTH@JTHjournal

Join #ESCardio oral session NOW: ‘Risk prediction and treatment options in cardio-oncology’ ▶️Simultaneous publication with @escardio congress: @KralerSimon & @FlorianMoik report on a novel risk score to predict cardiovascular risk in #cancer patients Look out for the paper, coming soon!! #Cardiotwitter

English
1
10
20
2.3K
Davide Ramoni retweetledi
Luca Liberale
Luca Liberale@liberale_luca·
Join us right now at Science Box 4 #ESCCongress as @KralerSimon present our results on CV risk stratification in patients with cancer. A great collaboration @UniGenova @cmc_uzh @MedUni_Wien @FlorianMoik @CarboneF82 @DavideRamoni @Cihan_Ay_MD @wenzl_florian @TomLuscher
JTH@JTHjournal

Join #ESCardio oral session NOW: ‘Risk prediction and treatment options in cardio-oncology’ ▶️Simultaneous publication with @escardio congress: @KralerSimon & @FlorianMoik report on a novel risk score to predict cardiovascular risk in #cancer patients Look out for the paper, coming soon!! #Cardiotwitter

English
0
6
7
1.1K
Davide Ramoni retweetledi
JTH
JTH@JTHjournal·
Join #ESCardio oral session NOW: ‘Risk prediction and treatment options in cardio-oncology’ ▶️Simultaneous publication with @escardio congress: @KralerSimon & @FlorianMoik report on a novel risk score to predict cardiovascular risk in #cancer patients Look out for the paper, coming soon!! #Cardiotwitter
JTH tweet media
English
2
5
9
4.9K

Keşfet

@liberale_luca @CarboneF82 @HemostasisToday @escardio @TomLuscher @EHJACVCEiC @cescobruno @UZH_en